Bowen Liu
No. 246 Baojian Road
Harbin, 150086, China
Harbin, 150086, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Combination of locoregional and systemic therapy for hepatocellular carcinoma with portal vein tumor thrombus: a real-world retrospective study.
Journal: Frontiers in oncology
Published: December 28, 2025
Correction: TACE-HAlC combined with Donafenib and immune checkpoint inhibitors for BCLC stage C HCC patients (THEME study): a retrospective IPTW-adjusted cohort study.
Journal: Frontiers in immunology
Published: November 13, 2025
TACE-HAIC Plus Targeted Therapy and Immunotherapy for HCC with Tumor Thrombus and Arteriovenous Fistula.
Journal: Journal of hepatocellular carcinoma
Published: October 21, 2025
TACE-HAlC combined with Donafenib and immune checkpoint inhibitors for BCLC stage C HCC patients (THEME study): a retrospective IPTW-adjusted cohort study.
Journal: Frontiers in immunology
Published: July 20, 2025
DTX1-mediated degradation of TUBB3 in Kupffer cells mitigates hepatocellular carcinoma progression by regulating M1/M2 polarization.
Journal: Communications biology
Published: June 16, 2025
Efficacy and safety of TACE-HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for the patients with BCLC-defined stage B-C HCC.
Journal: Frontiers in oncology
Published: April 21, 2025
Targeting RECQL4 in hepatocellular carcinoma: from prognosis to therapeutic potential.
Journal: BMC medical genomics
Published: November 02, 2024
Efficacy of transarterial chemoembolization-hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy in hepatocellular carcinoma with portal vein tumor thrombosis.
Journal: Oncology letters
Published: October 17, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026